Physiologically based pharmacokinetic modeling in obesity: applications and challenges-Reference-Cited by-同舟云学术

Physiologically based pharmacokinetic modeling in obesity: applications and challenges

Published:2024-08-12 Issue: Volume: Page:1-12
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Yang Ruwei¹,Ding Qin¹,Ding Junjie²,Zhu Liyong³,Pei Qi¹^ORCID

Affiliation:

1. Department of Pharmacy, The Third XiangyHospital, Central South University, Changsha, Hunan, China

2. Center for Tropical Medicine and Global Health, Oxford Medical School, Oxford, UK

3. Department of Gastrointestinal Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China

Funder

Natural Science Foundation of Hunan Province

Scientific Research Project of Hunan Provincial Administration of Traditional Chinese Medicine

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2024.2388690

Reference99 articles.

1. Implications of Obesity for Drug Therapy: Limitations and Challenges

2. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on

3. World Obesity Federation. World obesity atlas 2023. World Obesity Federation; 2023. Available from: https://data.worldobesity.org/publications/?cat=19

4. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study

5. Laparoscopic Roux‐en‐Y gastric bypass surgery influenced pharmacokinetics of several drugs given as a cocktail with the highest impact observed for CYP1A2, CYP2C8 and CYP2E1 substrates